Johannes Coy

1.1k total citations · 1 hit paper
12 papers, 912 citations indexed

About

Johannes Coy is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Johannes Coy has authored 12 papers receiving a total of 912 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in Johannes Coy's work include Cancer, Hypoxia, and Metabolism (4 papers), Diet and metabolism studies (3 papers) and RNA modifications and cancer (2 papers). Johannes Coy is often cited by papers focused on Cancer, Hypoxia, and Metabolism (4 papers), Diet and metabolism studies (3 papers) and RNA modifications and cancer (2 papers). Johannes Coy collaborates with scholars based in Germany, United Kingdom and France. Johannes Coy's co-authors include Daniela Diehl, Klavs Würgler Hansen, H. Döhner, Konstanze Fischer, Albert J. Poustka, Peter R. Galle, Peter Lichter, Axel Benner, Martin Volkmann and Martin Bentz and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Johannes Coy

12 papers receiving 895 citations

Hit Papers

p53 gene deletion predicts for poor survival and non-resp... 1995 2026 2005 2015 1995 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Johannes Coy Germany 10 490 356 332 225 221 12 912
Martin Trbušek Czechia 18 676 1.4× 484 1.4× 435 1.3× 346 1.5× 360 1.6× 51 1.2k
Benjamin L. Lampson United States 15 475 1.0× 348 1.0× 416 1.3× 215 1.0× 205 0.9× 30 942
Larry Mansouri Sweden 19 591 1.2× 397 1.1× 394 1.2× 307 1.4× 170 0.8× 37 944
Alicja Gruszka Italy 20 378 0.8× 380 1.1× 395 1.2× 112 0.5× 259 1.2× 36 945
Justyna Rawluk Germany 9 243 0.5× 126 0.4× 243 0.7× 260 1.2× 254 1.1× 28 666
Jana Šmardová Czechia 14 352 0.7× 296 0.8× 460 1.4× 250 1.1× 431 2.0× 57 1.0k
Meena Kanduri Sweden 24 368 0.8× 223 0.6× 1.1k 3.3× 194 0.9× 162 0.7× 45 1.5k
J V Melo United Kingdom 17 644 1.3× 150 0.4× 440 1.3× 145 0.6× 177 0.8× 27 1.3k
Y Frutiger United States 14 243 0.5× 183 0.5× 857 2.6× 207 0.9× 497 2.2× 16 1.4k
C. A. Griffin United States 10 65 0.1× 225 0.6× 475 1.4× 126 0.6× 368 1.7× 16 1.0k

Countries citing papers authored by Johannes Coy

Since Specialization
Citations

This map shows the geographic impact of Johannes Coy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johannes Coy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johannes Coy more than expected).

Fields of papers citing papers by Johannes Coy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johannes Coy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johannes Coy. The network helps show where Johannes Coy may publish in the future.

Co-authorship network of co-authors of Johannes Coy

This figure shows the co-authorship network connecting the top 25 collaborators of Johannes Coy. A scholar is included among the top collaborators of Johannes Coy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johannes Coy. Johannes Coy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Yan, Ming, Ralf Smeets, Martin Gosau, et al.. (2022). Tolerance of Human Fibroblasts to Benfo-Oxythiamine In Vitro. International Journal of Environmental Research and Public Health. 19(7). 4112–4112. 3 indexed citations
2.
Coy, Johannes. (2017). EDIM-TKTL1/Apo10 Blood Test: An Innate Immune System Based Liquid Biopsy for the Early Detection, Characterization and Targeted Treatment of Cancer. International Journal of Molecular Sciences. 18(4). 878–878. 20 indexed citations
3.
Parthier, C., et al.. (2010). The Crystal Structure of Human Transketolase and New Insights into Its Mode of Action. Journal of Biological Chemistry. 285(41). 31559–31570. 86 indexed citations
4.
Rieger, Johannes, Elke Hattingen, Gabriele D. Maurer, et al.. (2010). The ERGO trial: A pilot study of a ketogenic diet in patients with recurrent glioblastoma.. Journal of Clinical Oncology. 28(15_suppl). e12532–e12532. 10 indexed citations
5.
Völker, Hans‐Ullrich, Carsten Hagemann, Johannes Coy, et al.. (2008). Expression of Transketolase-like 1 and Activation of Akt in Grade IV Glioblastomas Compared With Grades II and III Astrocytic Gliomas. American Journal of Clinical Pathology. 130(1). 50–57. 27 indexed citations
6.
Földi, M, Elmar Stickeler, Oliver Kretz, et al.. (2007). Transketolase protein TKTL1 overexpression: A potential biomarker and therapeutic target in breast cancer. Oncology Reports. 17(4). 841–5. 65 indexed citations
7.
Coy, Johannes, Rainer Grobholz, Ralf‐Dieter Hofheinz, et al.. (2006). Expression of the mutated transketolase TKTL1, a molecular marker in gastric cancer. Oncology Reports. 16(4). 657–61. 44 indexed citations
8.
Götte, Karl, et al.. (2001). The relationship between allelic imbalance on 17p, p53 mutation and p53 overexpression in head and neck cancer. International Journal of Oncology. 19(2). 331–6. 10 indexed citations
9.
Götte, Karl, et al.. (2000). Cylindrical cell carcinomas of the paranasal sinuses do not show p53 alterations but loss of heterozygosity at 3p and 17p. International Journal of Cancer. 85(5). 740–740. 1 indexed citations
10.
Briault, Sylvain, Laurent Villard, Ute C. Rogner, et al.. (2000). Mapping of X chromosome inversion breakpoints [inv(X)(q11q28)] associated with FG syndrome: A second FG locus [FGS2]?. American Journal of Medical Genetics. 95(2). 178–181. 18 indexed citations
11.
Li‐Weber, Min, Oskar Laur, Armin Hekele, et al.. (1998). A regulatory element in the CD95 (APO-1/Fas) ligand promoter is essential for responsiveness to TCR-mediated activation. European Journal of Immunology. 28(8). 2373–2383. 52 indexed citations
12.
Döhner, H., Konstanze Fischer, Martin Bentz, et al.. (1995). p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias. Blood. 85(6). 1580–1589. 576 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026